Dr. Noel Moya to Present at the Diabetes Research Institute in Miami

Today we're pleased to share that our Chief Scientific Officer and co-founder, Dr. Noel Moya, has been invited to present at the Diabetes Research Institute (DRI) Research Conference Series at the University of Miami Miller School of Medicine on August 21, 2026.

His presentation,"Optimizing iPSC-Derived β-Cell Manufacturing for Translational Diabetes Therapy," will highlight our work advancing autologous iPSC-derived beta-cell manufacturing and the translational path toward a stem cell therapy for type 1 diabetes.

The DRI Research Conference Series brings together faculty, researchers, clinicians, and trainees to discuss advances spanning beta-cell biology, transplantation, immunology, diabetes technology, and translational research.

We're grateful for the opportunity to contribute to these scientific discussions and to share the progress our team has been making. Opportunities like these help move promising science closer to the patients who need it most.

If you'll be in South Florida that week and would like to meet with our team while we're in town, we'd be happy to connect. Simply reply to this email.

Thank you, as always, for following our journey.

Presentation at the DRI Research Conference does not constitute endorsement by the University of Miami, UHealth, or the Diabetes Research Institute.